Cost-effectiveness of oxaliplatin/5FU/LV (FOLFOX) vs. irinotecan/5FU/LV (IFL) as first-line treatment of metastatic colorectal cancer

Cost-effectiveness of oxaliplatin/5FU/LV (FOLFOX) vs. irinotecan/5FU/LV (IFL) as first-line treatment of metastatic colorectal cancer

2006

Aballea, S. | Najib, M. | Cure, S. | O'Neil, B. | Volume: 17, Issue: vi66, Pages: , colon cancer, cost-effectiveness analysis, poster,